Reviewing "The Myth of The Paperless Office" for the New Yorker in 2002, Malcolm Gladwell argued that if the computer had come first, and paper didn't exist, someone would have had to invent it.  Paper, it turns out, is a lot more useful than we typically appreciate.

Scott Gottlieb reviews Eric Topol's book on how medical innovation will coalesce to change clinical practice and what the coming changes mean for today's policy debates.

Biopharma – especially big pharma – gets all sorts of grief for being large, stodgy, and unable to innovate (or evolve); this Corey Goodman interview represents the perspective well.

Before writing off these companies entirely, however (an ignorant reaction in any case),...

Digital learning poses an immense dilemma when it comes to ensuring quality. In this paper, Hess explores the pros and cons of input regulation, outcome-based accountability, and market signals as solutions to the quality challenge.

This conference explored how technology and innovation have transformed the way consumers pay for purchases. It also looked at which reforms to current legislative and regulatory structures may be necessary to support continued payment innovation.

The Internet puts you a few clicks away from the best college lectures in America.

The crisis in financing is having a chilling effect on biomedical innovation. As discussed in my last column, the main problem in our industry is that the sheer cost of drug development has become almost prohibitively expensive, effectively pricing almost everyone but the largest companies out of the market.